X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Dr. Reddys - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs DR. REDDYS LAB - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD DR. REDDYS LAB MERCK LTD/
DR. REDDYS LAB
 
P/E (TTM) x 26.4 26.6 99.4% View Chart
P/BV x 3.0 2.7 108.1% View Chart
Dividend Yield % 1.0 1.0 92.4%  

Financials

 MERCK LTD   DR. REDDYS LAB
EQUITY SHARE DATA
    MERCK LTD
Dec-16
DR. REDDYS LAB
Mar-16
MERCK LTD/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,0604,383 24.2%   
Low Rs6232,750 22.7%   
Sales per share (Unadj.) Rs632.4920.1 68.7%  
Earnings per share (Unadj.) Rs45.7126.1 36.3%  
Cash flow per share (Unadj.) Rs62.3183.0 34.1%  
Dividends per share (Unadj.) Rs11.0020.00 55.0%  
Dividend yield (eoy) %1.30.6 233.1%  
Book value per share (Unadj.) Rs388.8685.8 56.7%  
Shares outstanding (eoy) m16.60170.61 9.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.33.9 34.3%   
Avg P/E ratio x18.428.3 65.1%  
P/CF ratio (eoy) x13.519.5 69.3%  
Price / Book Value ratio x2.25.2 41.6%  
Dividend payout %24.115.9 151.7%   
Avg Mkt Cap Rs m13,969608,481 2.3%   
No. of employees `0001.621.7 7.3%   
Total wages/salary Rs m1,48731,874 4.7%   
Avg. sales/employee Rs Th6,631.97,244.4 91.5%   
Avg. wages/employee Rs Th939.21,470.9 63.8%   
Avg. net profit/employee Rs Th479.4992.8 48.3%   
INCOME DATA
Net Sales Rs m10,498156,978 6.7%  
Other income Rs m2422,693 9.0%   
Total revenues Rs m10,741159,671 6.7%   
Gross profit Rs m1,13534,587 3.3%  
Depreciation Rs m2769,705 2.8%   
Interest Rs m0824 0.0%   
Profit before tax Rs m1,10226,751 4.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3435,237 6.6%   
Profit after tax Rs m75921,514 3.5%  
Gross profit margin %10.822.0 49.1%  
Effective tax rate %31.119.6 159.1%   
Net profit margin %7.213.7 52.7%  
BALANCE SHEET DATA
Current assets Rs m6,410118,201 5.4%   
Current liabilities Rs m8,82868,368 12.9%   
Net working cap to sales %-23.031.7 -72.6%  
Current ratio x0.71.7 42.0%  
Inventory Days Days5860 96.1%  
Debtors Days Days3897 39.6%  
Net fixed assets Rs m1,40672,265 1.9%   
Share capital Rs m166853 19.5%   
"Free" reserves Rs m6,286111,548 5.6%   
Net worth Rs m6,455117,009 5.5%   
Long term debt Rs m010,690 0.0%   
Total assets Rs m8,828200,104 4.4%  
Interest coverage xNM33.5-  
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.20.8 151.6%   
Return on assets %8.611.2 77.0%  
Return on equity %11.818.4 63.9%  
Return on capital %17.121.6 79.1%  
Exports to sales %8.346.3 17.9%   
Imports to sales %21.09.0 235.1%   
Exports (fob) Rs m86972,618 1.2%   
Imports (cif) Rs m2,20914,050 15.7%   
Fx inflow Rs m95975,405 1.3%   
Fx outflow Rs m2,61227,115 9.6%   
Net fx Rs m-1,65348,290 -3.4%   
CASH FLOW
From Operations Rs m1,07040,476 2.6%  
From Investments Rs m-750-19,421 3.9%  
From Financial Activity Rs m-150-17,009 0.9%  
Net Cashflow Rs m1714,046 4.2%  

Share Holding

Indian Promoters % 0.0 25.5 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 5.4 337.0%  
FIIs % 1.0 35.3 2.8%  
ADR/GDR % 0.0 18.5 -  
Free float % 29.1 15.3 190.2%  
Shareholders   28,591 75,885 37.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   SHASUN PHARMA  ORCHID PHARMA LTD  GSK PHARMA  J.B.CHEMICALS  SUN PHARMA  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Dr Reddy's: Major Business Segments Come Under Pressure (Quarterly Results Update - Detailed)

Sep 12, 2016

Dr Reddy's has announced the results for first quarter of FY17 (1QFY17). The company has reported decline in the sales by 13.9% YoY while net profits declined by 79.8 % YoY.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 21, 2017 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - CIPLA COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS